Inhibition of Sphingosine-1-Phosphate Receptor 2 by JTE013 Enhanced Alveolar Bone Regeneration by Promoting Angiogenesis
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24043401 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von William Lory und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Health Sciences, College of Dental Medicine, Medical University of South Carolina, Charleston, SC 29425, USA. Hauptthemen laut MEDLINE: Dimethyl Sulfoxide, Vascular Endothelial Growth Factor A. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDCR NIH HHS, NCATS NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Sphingosine-1-phosphate receptor 2 (S1PR2) is a G protein-coupled receptor that regulates various immune responses. Herein, we report the effects of a S1PR2 antagonist (JTE013) on bone regeneration. Murine bone marrow stromal cells (BMSCs) were treated with dimethylsulfoxide (DMSO) or JTE013 with or without infection by an oral bacterial pathogen Aggregatibacter actinomycetemcomitans. Treatment with JTE013 enhanced vascular endothelial growth factor A (VEGFA), platelet derived growth factor subunit A (PDGFA), and growth differentiation factor 15 (GDF15) gene expression and increased transforming growth factor beta (TGFβ)/Smad and Akt signaling. Eight-week-old male C57BL/6J mice were challenged with ligatures around the left maxillary 2nd molar for 15 days to induce inflammatory bone loss. After ligature removal, mice were treated with diluted DMSO or JTE013 in the periodontal tissues 3 times per week for 3 weeks. Calcein was also injected twice to measure bone regeneration. Micro-CT scanning of maxillary bone tissues and calcein imaging revealed that treatment with JTE013 enhanced alveolar bone regeneration. JTE013 also increased VEGFA, PDGFA, osteocalcin, and osterix gene expressions in the periodontal tissues compared to control. Histological examination of periodontal tissues revealed that JTE013 promoted angiogenesis in the periodontal tissues compared to control. Our findings support that inhibition of S1PR2 by JTE013 increased TGFβ/Smad and Akt signaling; enhanced VEGFA, PDGFA, and GDF15 gene expression; and subsequently promoted angiogenesis and alveolar bone regeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral Health Sciences, College of Dental Medicine, Medical University of South Carolina, Charleston, SC 29425, USA.
- Division of Laboratory Animal Resources, Medical University of South Carolina, Charleston, SC 29425, USA.
ORCID-Profile: Özlem Yilmaz, Hong Yu
Förderung
- NIDCR NIH HHS
- NCATS NIH HHS
- National Institutes of Health
Zitieren
APA
Lory, W., Wellslager, B., Sun, C., Yilmaz, Ö., & Yu, H. (2023). Inhibition of Sphingosine-1-Phosphate Receptor 2 by JTE013 Enhanced Alveolar Bone Regeneration by Promoting Angiogenesis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24043401
Vancouver
Lory W, Wellslager B, Sun C, Yilmaz Ö, Yu H. Inhibition of Sphingosine-1-Phosphate Receptor 2 by JTE013 Enhanced Alveolar Bone Regeneration by Promoting Angiogenesis. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24043401
BibTeX
@article{Lory2023,
author = {Lory, William and Wellslager, Bridgette and Sun, Chao and Yilmaz, Özlem and Yu, Hong},
title = {Inhibition of Sphingosine-1-Phosphate Receptor 2 by JTE013 Enhanced Alveolar Bone Regeneration by Promoting Angiogenesis},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24043401}
}
EUVIMED